Let me add a few additional ones:
- Brief (5-6 patients) clinical study about to commence.
- FDA process starting H2/2017
- Commercial sales start mid-2018
- Top two urologists working on this (Ralph deVere White, Edward M. Messing) are renowned in urology field throughout the US
- Management has worked together in prior biotech startups that have commercialized technology and were acquired by multinationals
- The technology greatly streamlines and shortens urology exams
- Bladder cancer is 6th most common cancer in US and is THE most recurring form of cancer
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM